NO920338L - Tricyklisk pyridonderivat - Google Patents

Tricyklisk pyridonderivat

Info

Publication number
NO920338L
NO920338L NO92920338A NO920338A NO920338L NO 920338 L NO920338 L NO 920338L NO 92920338 A NO92920338 A NO 92920338A NO 920338 A NO920338 A NO 920338A NO 920338 L NO920338 L NO 920338L
Authority
NO
Norway
Prior art keywords
pyridone derivative
compound
treatment
tricyclic pyridone
tricyclic
Prior art date
Application number
NO92920338A
Other languages
English (en)
Norwegian (no)
Other versions
NO920338D0 (no
Inventor
Richard Raimund Scherschlicht
Ulrich Widmer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO920338D0 publication Critical patent/NO920338D0/no
Publication of NO920338L publication Critical patent/NO920338L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/15Suppositories

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Electric Propulsion And Braking For Vehicles (AREA)
NO92920338A 1991-01-25 1992-01-24 Tricyklisk pyridonderivat NO920338L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH22891 1991-01-25

Publications (2)

Publication Number Publication Date
NO920338D0 NO920338D0 (no) 1992-01-24
NO920338L true NO920338L (no) 1992-07-27

Family

ID=4182207

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920338A NO920338L (no) 1991-01-25 1992-01-24 Tricyklisk pyridonderivat

Country Status (30)

Country Link
US (2) US5281711A (cs)
EP (1) EP0496274B1 (cs)
JP (1) JPH0739415B2 (cs)
KR (1) KR920014811A (cs)
AT (1) ATE140002T1 (cs)
AU (1) AU649302B2 (cs)
BG (1) BG61057B2 (cs)
BR (1) BR9200217A (cs)
CA (1) CA2058640A1 (cs)
CZ (1) CZ280258B6 (cs)
DE (1) DE59206676D1 (cs)
DK (1) DK0496274T3 (cs)
ES (1) ES2089252T3 (cs)
FI (1) FI920268A7 (cs)
GR (1) GR3021126T3 (cs)
HU (2) HU207072B (cs)
IE (1) IE920225A1 (cs)
IL (1) IL100702A (cs)
IS (1) IS3804A (cs)
LT (1) LT3473B (cs)
LV (1) LV10275B (cs)
MX (1) MX9200242A (cs)
MY (1) MY108199A (cs)
NO (1) NO920338L (cs)
NZ (1) NZ241341A (cs)
RU (1) RU2073678C1 (cs)
SI (1) SI9210067A (cs)
UY (1) UY23362A1 (cs)
YU (1) YU48221B (cs)
ZA (1) ZA92361B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0650966A1 (de) * 1993-10-28 1995-05-03 F. Hoffmann-La Roche Ag Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
KR100295740B1 (ko) 1998-09-17 2001-11-05 박영구 N-치환된-하이드록시고리화알킬아민유도체의제조방법
US7277767B2 (en) 1999-12-10 2007-10-02 Srs Labs, Inc. System and method for enhanced streaming audio
GB2410947B (en) * 2004-02-11 2008-09-17 Cambridge Lab Ltd Pharmaceutical compounds
DE602006004009D1 (de) * 2005-08-06 2009-01-15 Cambridge Lab Ireland Ltd 3,11b-cis-dihydrotetrabanezin zur behandlung von schizophrenie und anderen psychosen
WO2010058429A1 (en) 2008-11-24 2010-05-27 Council Of Scientific & Industrial Research A process for the preparation of optically active n-benzyl-3 hydroxypyrrolidines
WO2014190140A1 (en) 2013-05-23 2014-11-27 Alan Kraemer Headphone audio enhancement system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191427B (en) * 1984-07-16 1987-02-27 Budapesti Mueszaki Egyetem,Hu Piezooptical effect reduced electrooptical light modulator
US4889848A (en) * 1984-11-06 1989-12-26 Hoffmann-La Roche Inc. Tricyclic pyridine derivatives
ZW17385A1 (en) * 1984-11-06 1986-02-19 Hoffmann La Roche Tricyclic pyridine derivatives
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent

Also Published As

Publication number Publication date
DE59206676D1 (de) 1996-08-08
LV10275B (en) 1995-02-20
HU207072B (en) 1993-03-01
MX9200242A (es) 1992-07-01
UY23362A1 (es) 1992-07-21
KR920014811A (ko) 1992-08-25
HU211259A9 (en) 1995-11-28
SI9210067A (en) 1995-02-28
MY108199A (en) 1996-08-30
HU9200128D0 (en) 1992-04-28
ZA92361B (en) 1992-09-30
FI920268L (fi) 1992-07-26
CZ280258B6 (cs) 1995-12-13
RU2073678C1 (ru) 1997-02-20
NZ241341A (en) 1993-12-23
BR9200217A (pt) 1992-10-06
YU48221B (sh) 1997-08-22
US5326769A (en) 1994-07-05
JPH04312585A (ja) 1992-11-04
DK0496274T3 (da) 1996-09-23
IE920225A1 (en) 1992-07-29
EP0496274B1 (de) 1996-07-03
US5281711A (en) 1994-01-25
LTIP801A (en) 1995-02-27
BG61057B2 (bg) 1996-09-30
YU6792A (sh) 1994-11-15
CS18292A3 (en) 1992-08-12
FI920268A7 (fi) 1992-07-26
ES2089252T3 (es) 1996-10-01
IS3804A (is) 1992-07-26
LV10275A (lv) 1994-10-20
JPH0739415B2 (ja) 1995-05-01
LT3473B (en) 1995-10-25
FI920268A0 (fi) 1992-01-22
AU649302B2 (en) 1994-05-19
GR3021126T3 (en) 1996-12-31
ATE140002T1 (de) 1996-07-15
IL100702A0 (en) 1992-09-06
NO920338D0 (no) 1992-01-24
IL100702A (en) 1995-08-31
EP0496274A1 (de) 1992-07-29
CA2058640A1 (en) 1992-07-26
AU1034092A (en) 1992-07-30
HUT60266A (en) 1992-08-28

Similar Documents

Publication Publication Date Title
UA48946C2 (uk) Арилалкілдіазинони, спосіб їх одержання (варіанти), фармацевтичний склад, спосіб його одержання та спосіб лікування
IL110672A (en) 4-Substituted piperidine derivatives pharmaceutical compositions containing them and process for their manufacture
MY106259A (en) 2-aminopyrimidinone derivatives.
AU658619B2 (en) Benzopyranones, methods of manufacture and use thereof
PL309225A1 (en) Pharmacologically active derivatives of pyridine and methods of obtaining them
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
DE69620306D1 (de) 4-(.Alpha.-hydroxy-.alpha.-aryl-alkylcarbonylamino)-Piperidine zur Behandlung und Prophylaxe von Erkrankungen der Harnwege
NO920338L (no) Tricyklisk pyridonderivat
FI922979A7 (fi) 2-(piperidin-1-yyli)etanolijohdannaiset, niiden valmistus ja terapeuttinen käyttö
NO914056L (no) Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat
ZA918293B (en) 1-(3,4-dihydro-2-oxo-1h-quinolin-6-yl)-2(4-(2-phenylethyl)piperidin-1-yl)ethanol and-ethanone,their preparation and their therapeutic application
IL97734A0 (en) Benzoxazine derivatives,process for their preparation and their use for treatment or for the prophylaxis of diseases
ATE229336T1 (de) Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern
FR2688504B1 (fr) Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
BG102678A (en) 1,4-dihydropyridine compounds as bradykinin antagonists
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
NO20021310L (no) Aminderivater
ATE134135T1 (de) Ein imidazobenzodiazepin zur behandlung von schlafstörungen
DE69429538D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
MD1195F1 (en) Hemotherapy remedy
FR2678265B1 (fr) Derives de 4-(2-phenylethyl)piperidine, leur preparation et leur application en therapeutique.
FR2678270B1 (fr) Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
UA37488A (uk) Спосіб лікування хронічного кон'юнктивіту
FR2689891B3 (fr) Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
MX9602559A (es) Nuevos derivados de piperidina con actividad antagonista del paf.